-
What is ImQuest, and How is Statera Biopharma using it to Develop New Immune Therapies for Cancer, Infectious Disease and Autoimmune Disorders?
Previously Published to Benzinga: The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. Statera Biopharma, Inc. (NASDAQ: STAB) — the company formerly known as Cytocom (NASDAQ: CBLI) — recently uplisted to the Nasdaq in lieu of earlier acquisitions involving Cleveland BioLabs and ImQuest Life Sciences, Inc. Last week, the company provided an update on its integration of ImQuest and its plans going forward. According to Statera, preclinical testing is underway in the screening of second-generation immune therapies using the ImQuest platform for the rapid and accurate assessment of various diseases and how the overall makeup and composition of these diseases interact. The company will look more closely…
- Smart Buildings, Benzinga, Business, CleanTech, Finance, GreenTech, Health, IoT, Smart Cities, Technology
Delphi360™ to Officially Launch, Improve the Work Environment and Change Indoor Air Quality Forever
Previously Published to Benzinga: The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. The overall quality of indoor air at the office is taking center stage for many businesses. Cleaner air means a safer environment. And a safer environment leads to corporate trust and satisfaction. Society spends approximately 90% of its time indoors, and nearly 50% of this time includes working for hours on end in poor indoor air quality (IAQ). The invisible air-quality-killing demons that commercial office buildings produce contribute to more than 39% of the world’s energy-related carbon dioxide emissions — and, the truth is,…
-
Statera BioPharma: The Ticker Formerly Known as CBLI
Previously Published to Benzinga: The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. On September 1, 2021, Cytocom officially became listed as Statera BioPharma, Inc. (NASDAQ: STAB), as it updated its ticker symbol from CLBI to STAB within the Nasdaq markets. This change in name comes as a natural progression, as the company shifts gears toward placing a more strategic focus on restoring total immune health — including autoimmune and inflammatory diseases, such as fibromyalgia and multiple sclerosis, blood disorders like anemia and lupus, even cancer and various other infectious diseases. The company began trading as CLBI, last month,…
-
Biotricity Reports Q1 Earnings at 290% for FY2022
Previously Published to Benzinga: The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. Biotricity (NASDAQ: BTCY) has been taking the world of medtech by storm, introducing primary care providers across the country to its remote heart monitoring devices. Always connected, these wearable devices have been giving power back to those suffering from chronic cardiac conditions and simultaneous comorbidities — the simultaneous presence of two or more diseases or medical conditions and often relative of one another. Through remote heart monitoring and diagnostic technologies, doctors can screen their patients from a distance, even alerted to a possible emergency if the…
-
Generation Hemp’s Green Policy is Inspired by a Cause, Executives Move From Oil and Gas to Industrial Green
Previously Published to Benzinga: The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. Generation Hemp, Inc. (OTCQB: GENH) is creating its own “Industrial Evolution,” leading an industry by example and contributing to a greener tomorrow. Ironically as it may seem, the company’s lead principals were once major players in the oil and gas industry — a notoriously sharp contrast to anything the world sees as “green.” To them, the frontier in “all things cannabis” is more than just a trend. They want to give back to the environment and cut back on the carbon footprint — a modus…
